Cargando…
Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis
A patient with Multifocal Reticulohistiocytosis (MRH) of skin and joints failed treatment with etanercept, methotrexate, hydroxychloroquine, prednisone, bisphosphonates and hydroxyzine. Long term treatment with thalidomide led to marked improvement in joint and cutaneous manifestations.
Autores principales: | Zinn, Daniel J, Eckstein, Olive, Olsen, Mary L, Allen, Carl E, McClain, Kenneth L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289025/ https://www.ncbi.nlm.nih.gov/pubmed/32529194 http://dx.doi.org/10.35248/2684-124X.19.4.152 |
Ejemplares similares
-
Multicentric reticulohistiocytosis
por: Shah, Sejal P., et al.
Publicado: (2011) -
Clinical Images: Multicentric reticulohistiocytosis
por: Lucke, Michael
Publicado: (2023) -
Multicentric Reticulohistiocytosis Presenting As Acute Pericarditis With Moderate-Sized Pericardial Effusion: A Case Report and Review of Multicentric Reticulohistiocytosis Treatment
por: Mandyam, Saikiran, et al.
Publicado: (2023) -
Organizing pneumonia associated with multicentric reticulohistiocytosis
por: Yoshimura, Katsuhiro, et al.
Publicado: (2015) -
Multicentric Reticulohistiocytosis with Dermatomyositis-like Eruptions
por: Shima, Natsuki, et al.
Publicado: (2017)